Off-Label Uses of Sorafenib and Sunitinib
This is a discussion on Off-Label Uses of Sorafenib and Sunitinib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; Sorafenib (Nexavar®) and sunitinib (Sutent®) are orally administered inhibitors of protein tyrosine kinases associated with the intracellular portions of certain ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-10-2008, 04:01 PM
|
|||
|
|||
Off-Label Uses of Sorafenib and Sunitinib
Sorafenib (Nexavar®) and sunitinib (Sutent®) are orally administered inhibitors of protein tyrosine kinases associated with the intracellular portions of certain transmembrane receptor molecules. Each targets the tyrosine kinase activity of more than one receptor, with effects that depend on each cell type’s receptor repertoire.
More... Last edited by chantell.reagan : 05-13-2008 at 09:12 AM. 
|
Linear Mode
